Contractor Advisory Committee (CAC) Meeting Information - Oxygen and Oxygen Equipment (L33797) - JA DME
Contractor Advisory Committee (CAC) Meeting Information - Oxygen and Oxygen Equipment (L33797)
Joint DME MAC Publication
The Centers for Medicare and Medicaid Services (CMS) assigned to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) the task of developing local coverage determinations (LCDs) for processing and reviewing Medicare claims for Durable Medical Equipment, Prostheses, Orthoses, and Supplies (DMEPOS). The DME MACs have received requests from E02 Concepts and GWR Medical, Inc. to revise the Oxygen and Oxygen Equipment LCD to include language indicating that Topical Oxygen is reasonable and necessary for wound healing therapy. The purpose of this Specialty Focused CAC is to discuss the scientific evidence underlying the requested LCD revisions.
The Contractor Advisory Committee (CAC) meeting will take place on October 29, 2019 in San Francisco, CA at the Hilton San Francisco Union Square 333 O'Farrell St, San Francisco, CA 94102. The CAC meeting will begin at 2:00 PM and is scheduled to end at 5 p.m. PM (all times PDT). Interested stakeholders are invited to attend in-person or listen via teleconference; however, advance registration is required, whether attending in-person or via teleconference. Registration is available at (Event has passed. Registration link no longer available.) Once registered you will receive the teleconference information via email prior to the meeting. Lines will remain muted throughout the conference except for the invited CAC members and the DME MAC hosts. Registration must be received no later than Friday, October 18, 2019.
CAC members will be asked to discuss the clinical literature related to the LCD reconsideration request and to score a series of Key Questions. Discussions will occur between CAC members. The public may attend; however, presentations or questions to CAC members from the public will not be permitted. Once a proposed LCD is posted, a 45-day comment period will commence, affording stakeholders a chance to submit written comments, along with an Open Meeting to afford a chance to provide any additional verbal comments.
Refer to each DME MAC website for additional information about policy development process.
Thank you for your participation in our policy development process.
Sincerely,
/s/
Wilfred Mamuya, MD, PhD
On behalf of:
Wilfred Mamuya, MD, PhD
Medical Director, DME MAC, Jurisdiction A
Noridian Healthcare Solutions, LLC
Stacey V. Brennan, MD, FAAFP
Medical Director, DME MAC, Jurisdiction B
CGS Administrators, LLC
Robert D. Hoover, Jr., MD, MPH, FACP
Medical Director, DME MAC, Jurisdiction C
CGS Administrators, LLC
Peter J. Gurk, MD, CPE, CHCQM
Medical Director, DME MAC, Jurisdiction D
Noridian Healthcare Solutions, LLC
